Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Integrin-PET uptake evaluation in patients receiving pulmonary radiotherapy

Azeem Saleem, Yusuf Helo, Graham Searle, Zarni Win, Jo Cook, Roger Gunn and Paula Wells
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 295;
Azeem Saleem
1Invicro, A Konica Minolta Company London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuf Helo
1Invicro, A Konica Minolta Company London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Searle
1Invicro, A Konica Minolta Company London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zarni Win
2NM Department London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jo Cook
4Radiotherapy Physics St Bartholomew's Hospital London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Gunn
1Invicro, A Konica Minolta Company London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Wells
3Radiotherapy St Bartholomew's Hospital London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

295

Objectives: Integrin αvβ6, an epithelial-specific integrin is not expressed in healthy adult epithelia but is upregulated during wound healing, in cancer and activates Transforming Growth Factor (TGF). TGF β-1, which plays a key role in the fibrotic pathway. Pre-clinical studies have demonstrated that αvβ6 integrin expression in alveolar epithelium increases after radiotherapy (RT) before onset of fibrosis, and anti- αvβ6 therapy prevents fibrogenesis [1]. Lung fibrosis presents as progressive pulmonary injury and is a major barrier to improved cure rate after pulmonary radiotherapy in patients with non-small cell lung cancer (NSCLC). In this study, the utility of PET imaging with a αvβ6 integrin ligand was evaluated in patients with non-small cell lung cancer following pulmonary RT. Subjects with NSCLC who had received pulmonary RT within 6 months were recruited. PET imaging of the lungs over 60 minutes was performed after administration of a fluorine-18 radiolabelled 20 amino acid αvβ6-specific peptide ligand, [18F]-FBAA20FMDV2 (IMAFIB; Cancer Research Technologies (CRT) patented). PET-CT scans were co-registered with the RT planning (RTP) scans and segmented to regions corresponding to RT doses of > 40 Gy (excluding tumour), 25-40 Gy, 15-25 Gy, 8-15 Gy and < 8 Gy. Time activity curves and the standardised uptake values (SUVs) were calculated and comparisons made between RT dose and PET uptake (SUV). Linear regression between SUV and RT dose was performed for each subject and normalised to an intercept of 1. Six subjects (3M; 3F) aged 51-75 years underwent an IMAFIB-PET scan between 6 - 22 weeks after RT completion and mean IMAFIB radioactivity of 45.4 (range 8.9 - 122) MBq administered. Five subjects received conformal external beam RT, while one subject received stereotactic RT (SBRT). Biological effective doses (BED) using the linear quadratic cell survival radiobiology model [2] were calculated for pneumonitis (α/β = 5) and lung fibrosis (α/β = 3). The averaged normalised SUV across all subjects increased monotonically with RT dose (figure), between 1.05 ± 0.14 at 4 Gy and 1.58 ± 0.31 at 52 Gy. A correlation between a higher IMAFIB PET uptake (SUV) and higher RT doses received by the lung was observed in all subjects with a significant relationship (p < 0.05) in 3 of the 6 subjects, all of whom received hypo-fractionated RT regimens (table).

View this table:
  • View inline
  • View popup

[asterisk]BED not calculated (NC) for SBRT regimen. A relationship between IMAFIB PET uptake and RT dose is consistent with RT dose-related activation of αvβ6 integrin in the irradiated lung and to the induction of lung fibrosis in subjects receiving pulmonary RT.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Integrin-PET uptake evaluation in patients receiving pulmonary radiotherapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Integrin-PET uptake evaluation in patients receiving pulmonary radiotherapy
Azeem Saleem, Yusuf Helo, Graham Searle, Zarni Win, Jo Cook, Roger Gunn, Paula Wells
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 295;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Integrin-PET uptake evaluation in patients receiving pulmonary radiotherapy
Azeem Saleem, Yusuf Helo, Graham Searle, Zarni Win, Jo Cook, Roger Gunn, Paula Wells
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 295;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Evolution of the Gold Standard: Gastric Emptying scintigraphy beyond total gastric emptying.
  • Exploring variations and utility of FDG- and NaF PET/CT in rheumatoid arthritis and osteoarthritis
  • Application of Lung perfusion only scan combined with SPECT/CT for the post-treatment evaluation of massive and sub-massive pulmonary embolism in the age of covid-19 pandemic: case presentation and literature review
Show more General Clinical Specialties

Outcomes/Infectious Disease/Pulmonary II

  • Collagen-Targeted PET Imaging in Pulmonary Fibrosis: Initial Human Experience
  • CT guided Technetium-99m Macroaggregated albumin injection for lung nodule localization prior to video-assisted thoracoscopic surgery: A single institutional experience
  • 3D-Quantitated lung perfusion 99mTc-MAA SPECT/CT: Impact on intended management in comparison to planar (2D) lung perfusion scan in lung cancer patients
Show more Outcomes/Infectious Disease/Pulmonary II

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire